Autonomous Allergic Reaction Response System

A next-generation, wearable, and autonomous system that detects and responds to allergic reactions, providing personalized emergency response plans and medication administration.

The original tamper-evident closure container patent addressed the need for proper preparation and access to equipment in emergency situations, but it did not account for the complexities of modern allergic reactions. The new inventive concept solves the problem of delayed or inadequate response to allergic reactions by introducing autonomous detection, personalized response plans, and advanced medication administration.

The Autonomous Allergic Reaction Response System comprises a wearable, autonomous container that detects allergic reactions and injects medication via a retractable needle. The system is powered by a bio-compatible energy harvesting system and features interchangeable cartridges containing different medications. The system also includes a sensor for detecting expiration dates and medication levels, and a user interface for tracking and managing medication regimens. Furthermore, the system integrates with a network-enabled, AI-powered platform for monitoring and responding to allergic reactions, providing personalized alerts and instructions to users and emergency responders.

The new claims introduce autonomous detection and response capabilities, wearable and implantable devices, and AI-powered platforms, which are not present in the original patent. These features provide a significant inventive step, enabling a more comprehensive and effective response to allergic reactions.

Alternative embodiments of the Autonomous Allergic Reaction Response System could include implantable devices with longer lifetimes, or integration with existing wearable devices such as smartwatches. Variations could also include different types of medication administration, such as inhalers or transdermal patches.

The Autonomous Allergic Reaction Response System has significant commercial potential in the healthcare and medical device industries, particularly in the areas of emergency response, allergy treatment, and personalized medicine. The system could be marketed to individuals with severe allergies, as well as to healthcare providers and emergency responders.